Staar Surgical CoSTAA -2.85%83 Receivables Turnover is 1.43 as of Mar. 2026. GuruFocus rates STAA with a GF Score™ of 83/100 and a GF Value™ of $31.71 (Modestly Undervalued). The stock has 5 warning signs investors should review. Among 812 Medical Devices & Instruments companies, Staar Surgical Co ranks worse than 50.86% on this metric.
The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Staar Surgical Co's Revenue for the
three
months ended in Mar. 2026 was $93.5 Mil. Staar Surgical Co's average Accounts Receivable for the
three
months ended in Mar. 2026 was $65.6 Mil.
Hence, Staar Surgical Co's Receivables Turnover for the
three
months ended in Mar. 2026 was 1.43.
Staar Surgical Co (NAS:STAA) Receivables Turnover Explanation
An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.
Staar Surgical Co Receivables Turnover Related Terms
Staar Surgical Co Receivables Turnover Historical Data
* Premium members only.
The historical data trend for Staar Surgical Co's Receivables Turnover can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
STAA vs BLFS, ATRC, KMTS: Receivables Turnover Comparison
For the Medical Instruments & Supplies subindustry, Staar Surgical Co's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Staar Surgical Co Receivables Turnover vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Staar Surgical Co's Receivables Turnover distribution charts can be found below:
* The bar in red indicates where Staar Surgical Co's Receivables Turnover falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Staar Surgical Co (STAA) has a Receivables Turnover of 1.43 as of Mar. 2026. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Staar Surgical Co and its competitors. According to the industry distribution chart, Staar Surgical Co ranks #413 out of 812 companies in the Medical Devices & Instruments industry, placing it in the top 50.9%.
Is Staar Surgical Co's Receivables Turnover too high?
Staar Surgical Co's current Receivables Turnover is 1.43. The Medical Devices & Instruments industry median Receivables Turnover is 5.53. Staar Surgical Co's value of 1.43 is 74.1% below this industry median. Based on the distribution chart, Staar Surgical Co ranks #413 out of 812 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Staar Surgical Co has a GF Score™ of 83/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Staar Surgical Co's Receivables Turnover compare to BLFS and ATRC?
According to the Medical Devices & Instruments industry distribution chart, Staar Surgical Co ranks #413 out of 812 companies for Receivables Turnover. This places Staar Surgical Co in the lower half of its industry. The industry median Receivables Turnover is 5.53. Staar Surgical Co's value of 1.43 is 74.1% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Receivables Turnover for a Medical Devices & Instruments company?
The median Receivables Turnover among Medical Devices & Instruments companies is 5.53, based on 812 companies in the industry. Companies in the top quartile (top 25%) have a Receivables Turnover significantly above this median, while those in the bottom quartile fall well below. However, Receivables Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Staar Surgical Co's current Receivables Turnover of 1.43 is 74.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Receivables Turnover mean?
A high Receivables Turnover can signal that a stock is expensive relative to its fundamentals. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Staar Surgical Co and its competitors. For the Medical Devices & Instruments industry, the median Receivables Turnover is 5.53 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Staar Surgical Co's current Receivables Turnover is 1.43. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Staar Surgical Co stock overvalued right now?
Based on GuruFocus' analysis, Staar Surgical Co (STAA) is currently considered Modestly Undervalued. The stock's GF Value™ is $31.71, compared to a current price of $26.54 — trading 16.3% below its estimated fair value. The current Receivables Turnover is 1.43 and 74.1% below the Medical Devices & Instruments industry median of 5.53. Staar Surgical Co's overall GF Score™ is 83/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Receivables Turnover calculated?
Receivables Turnover is calculated from a company's financial statements. For Staar Surgical Co (STAA), the current Receivables Turnover is 1.43 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Staar Surgical Co (STAA) Overvalued in 2026?
Based on GuruFocus' analysis, Staar Surgical Co stock appears to be undervalued.
The current stock price of $26.54 is trading 16.3% below its estimated GF Value™ of $31.71.
GuruFocus considers Staar Surgical Co to be Modestly Undervalued.
Key valuation signals for STAA:
Receivables Turnover: 1.43
GF Value™: $31.71 vs. price of $26.54 (16.3% below fair value)
Industry Position: 74.1% below the Medical Devices & Instruments median (#413 of 812)
No single metric tells the full story. See the STAA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company offers two types of products: Implantable Collamer lenses (ICL), which are used in refractive surgery. The company generates almost all of its revenue from the sale of its ICL products. Geographically, the company generates key revenue from Foreign sales.
83GF Score
Get the complete analysis for STAA
Receivables Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STAA has been successfully added to your 
